Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why

The most recent trading session ended with Oscar Health, Inc. (OSCR) standing at $13.45, reflecting a +1.74% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily gain of 0.64%. On the other hand, the Dow registered a gain of 0.85%, and the technology-centric Nasdaq increased by 0.31%.Coming into today, shares of the company had lost 1.78% in the past month. In that same time, the Finance sector lost 4.63%, while the S&P 500 lost 7.69%.Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company's upcoming EPS is projected at $0.83, signifying a 33.87% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.8 billion, up 30.75% from the year-ago period.Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $0.69 per share and revenue of $11.04 billion, indicating changes of +590% and +20.34%, respectively, compared to the previous year.It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #3 (Hold).With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 19.16. This expresses a premium compared to the average Forward P/E of 10.16 of its industry.The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 64, putting it in the top 26% of all 250+ industries.The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks